Post Reply
101-120 of 1114
[Speed of coronavirus vaccine race ' crazy' and unsafe, scientists warn]
Leading scientists across the world have said rushing the development of a coronavirus vaccine to bring it to the public before the end of this year is unrealistic, unsafe, and even " crazy" . Despite reports from across the world suggesting a vaccine could be ready in weeks - particularly from the United States, where " Operation Warp Speed" reportedly has officials on standby to distribute the vaccine by October, ahead of the presidential election - experts are increasingly concerned that the rhetoric is in no way matched by the data.
None of the leading vaccine candidates have yet completed clinical trials, the regulatory bodies who licence vaccines are already struggling to cope with coronavirus demands, and questions over manufacture and distribution haven' t been considered, experts say. Professor Beate Kampmann, director of the Vaccine Centre at the London School of Hygiene and Tropical Medicine, told The Telegraph: " This timeline is neither realistic, nor is it sensible to put this kind of pressure on the analysis of important trials. It is highly politicised, and I am not a fan of this approach."
She said that it was essential for all new vaccines to go through comprehensive clinical trials. In normal times, a vaccine takes up to ten years to develop, including several years of testing. Under the current plans outlined by politicians in the UK, Russia, and the United States, this has been crunched to less than 12 months. " It is extremely unwise to proceed with licensing any vaccine without a proven track record for safety and efficacy, in any country," Professor Kampmann said. " If they are found to be useless or even dangerous, you might jeopardise the entire vaccine programme. The more this moves from science into politics, the more it becomes a little crazy."
The World Health Organization said on Friday it does not expect to see a vaccine until mid-2021, and it is working with experts to define the criteria for declaring a vaccine successful. At the same time, the head of ' Operation Warp Speed' in the US, Dr Moncef Slaoui, hit back at accusations of political influence, telling Science Magazine he would resign if there was " undue interference" . But the data gaps are plain to see. According to a vaccine tracker from the Vaccine Centre, there are 210 vaccine candidates - some involving totally new technology - in development.
Nine of them are at the final stage of trials, Phase III. This stage tests the vaccine on thousands of people to hunt for potential side-effects, as well as checking the jab actually works. However, none - including the leading Oxford University candidate, as well as Chinese, German and US bids - have completed it, and some are still recruiting for volunteers. T
ens of thousands of people are expected to be needed in countries across the world. And if the speed of development and testing is unprecedented, the speed with which regulatory bodies and governments will have to assess the evidence for the vaccines is, too. In the past this has taken between one and two years. Now, regulatory bodies are suggesting they can do it in months - in the UK, the Medicines and Healthcare products Regulatory Agency (MHRA) has said just 70 days. That is ambitious, to say the least, and not only because the MHRA' s experience in licensing vaccines is limited. In the past, while the UK was part of the European Union, it usually relied on the much larger European Medicines Agency (EMA) for licences (and in fact, still does, until the end of the Brexit transition period). That body warned this week that it was already struggling to cope with its coronavirus workload amid staff shortages after Brexit forced its relocation from London to Amsterdam. Meanwhile, the MHRA is set for new powers and resources from the UK government to sift through the evidence more quickly and license a vaccine.
But even if a new vaccine does get licensed, that " doesn' t mean it' s in a clinic next to your home in the next two weeks" , cautioned Professor Kampmann. Many manufacturing and logistical hurdles remain. And the problem is almost everyone involved in this process is not used to acting with this kind of urgency. " We have never seen anything like this, and the incentives to cut corners are greater than has ever been the case, and that' s the trouble," Dr Stuart Blume, an expert in the history of vaccines at the University of the Netherlands, told The Telegraph. " We all want a vaccine but the fact that it is taking place under these political and economic circumstances is disastrous in my view," he said. History shows that things have gone wrong before when vaccines have been rushed through, including unleashing rare side effects on the general population.
https://sg.news.yahoo.com/speed-coronavirus-vaccine-race-crazy-183938089.html
Leading scientists across the world have said rushing the development of a coronavirus vaccine to bring it to the public before the end of this year is unrealistic, unsafe, and even " crazy" . Despite reports from across the world suggesting a vaccine could be ready in weeks - particularly from the United States, where " Operation Warp Speed" reportedly has officials on standby to distribute the vaccine by October, ahead of the presidential election - experts are increasingly concerned that the rhetoric is in no way matched by the data.
None of the leading vaccine candidates have yet completed clinical trials, the regulatory bodies who licence vaccines are already struggling to cope with coronavirus demands, and questions over manufacture and distribution haven' t been considered, experts say. Professor Beate Kampmann, director of the Vaccine Centre at the London School of Hygiene and Tropical Medicine, told The Telegraph: " This timeline is neither realistic, nor is it sensible to put this kind of pressure on the analysis of important trials. It is highly politicised, and I am not a fan of this approach."
She said that it was essential for all new vaccines to go through comprehensive clinical trials. In normal times, a vaccine takes up to ten years to develop, including several years of testing. Under the current plans outlined by politicians in the UK, Russia, and the United States, this has been crunched to less than 12 months. " It is extremely unwise to proceed with licensing any vaccine without a proven track record for safety and efficacy, in any country," Professor Kampmann said. " If they are found to be useless or even dangerous, you might jeopardise the entire vaccine programme. The more this moves from science into politics, the more it becomes a little crazy."
The World Health Organization said on Friday it does not expect to see a vaccine until mid-2021, and it is working with experts to define the criteria for declaring a vaccine successful. At the same time, the head of ' Operation Warp Speed' in the US, Dr Moncef Slaoui, hit back at accusations of political influence, telling Science Magazine he would resign if there was " undue interference" . But the data gaps are plain to see. According to a vaccine tracker from the Vaccine Centre, there are 210 vaccine candidates - some involving totally new technology - in development.
Nine of them are at the final stage of trials, Phase III. This stage tests the vaccine on thousands of people to hunt for potential side-effects, as well as checking the jab actually works. However, none - including the leading Oxford University candidate, as well as Chinese, German and US bids - have completed it, and some are still recruiting for volunteers. T
ens of thousands of people are expected to be needed in countries across the world. And if the speed of development and testing is unprecedented, the speed with which regulatory bodies and governments will have to assess the evidence for the vaccines is, too. In the past this has taken between one and two years. Now, regulatory bodies are suggesting they can do it in months - in the UK, the Medicines and Healthcare products Regulatory Agency (MHRA) has said just 70 days. That is ambitious, to say the least, and not only because the MHRA' s experience in licensing vaccines is limited. In the past, while the UK was part of the European Union, it usually relied on the much larger European Medicines Agency (EMA) for licences (and in fact, still does, until the end of the Brexit transition period). That body warned this week that it was already struggling to cope with its coronavirus workload amid staff shortages after Brexit forced its relocation from London to Amsterdam. Meanwhile, the MHRA is set for new powers and resources from the UK government to sift through the evidence more quickly and license a vaccine.
But even if a new vaccine does get licensed, that " doesn' t mean it' s in a clinic next to your home in the next two weeks" , cautioned Professor Kampmann. Many manufacturing and logistical hurdles remain. And the problem is almost everyone involved in this process is not used to acting with this kind of urgency. " We have never seen anything like this, and the incentives to cut corners are greater than has ever been the case, and that' s the trouble," Dr Stuart Blume, an expert in the history of vaccines at the University of the Netherlands, told The Telegraph. " We all want a vaccine but the fact that it is taking place under these political and economic circumstances is disastrous in my view," he said. History shows that things have gone wrong before when vaccines have been rushed through, including unleashing rare side effects on the general population.
https://sg.news.yahoo.com/speed-coronavirus-vaccine-race-crazy-183938089.html
maarifat ( Date: 06-Sep-2020 20:39) Posted:
|
Anybody can advise how to transfer from whats app to this forum as I have numerours rep
- Download Opera browser.. Ther' s a wrkspae whereby you can toggle between Whats App m Telgram, FaceBook and Opera browser.. https://www.opera.com
- Download Opera browser.. Ther' s a wrkspae whereby you can toggle between Whats App m Telgram, FaceBook and Opera browser.. https://www.opera.com
Anybody can create telegram which I can post there for reference??
Anybody can advise how to transfer from whats app to this forum as I have numerours reports??
Where the report?
look@bright ( Date: 06-Sep-2020 19:34) Posted:
|
Credit Suisse yes but its in my What's App.
Just do not know how to cut abd paste.
someone says there is report from CIMB and Credit Credit Suisse, anybody has it to share?
SinoThai1688 ( Date: 02-Sep-2020 18:03) Posted:
|
No, I am a Sporean but from the rubber fraternity.
Just curious are you from Thailand?
limjoeseph ( Date: 06-Sep-2020 18:12) Posted:
|
Fyi I bought again on a joint account with a friend 50K last week at S$1.19 as I shall be holding for the next few quarters on strong earnings for 3rd quarters of at least min. US$77 million of 56% from STGT projected potential earnings of US$138 million even without taking into account of rubber division profits as expounded by STA Management that the 3rd quarters rubber results will be much better than 2nd quarters.
Staying invested until 1st half june 2021 still better for choice.
Last few days/ week i remembered a few guys say this lousy leh , asking to sell lor
lol
lol
To all my fellow loyal STA Sing holders, today I bought 50K STA Sing at $1.17 a slight discount to STA Thai at 27.75 baht to prove that my ABCDE technical pattern is self fulfiling after breaking above the whipsaw range berween 25.25 and 26.75 baht.
So far I do not have target objective for this short term trade on STA Sing but will monitor for the next few days.
For my long STA Thai with a group of Asian investors from the rubber fraternity of 40 million STA shares at 28.25 baht which is a buy and hold purchase until 1st half June 2021 as we have prvileged info from our Thai informant very familiar with the STA business model that we remain invested.
We have done our due diligence and will hold to suit our risk appetite.
Like I said, any close above STA Thai above 26.75 baht is a confirmed breakup on ABCDE pattern. Looks like STA Thai has taken notice of a rising rubber price short term catalyst to attract speculative buying today to reverse itself out of a whipsaw short term range between 25.25 and 26.75 baht. Therefore, I can say that dip buying is better for choice. STA Sing will follow suit but please do not overpay STA Sing higher than STA Thai in baht terms as STA Thai is the lead mkt. Besides foreign fund instituitons including local ones have been buying into the recent drop from 29 baht down to 25.25 baht whilst profit retail investors' liquidation was well absorbed as evident from their recised upward target proce for a 12 months time frame. The trend has more or less started to be your friend from todays technical breakup ln STA Thai. Stay invested to reap your reward for a buy and hold strategy until 1st half June 2021.
https://www.bangkokpost.com/business/1978547/gloves-vaccines-shape-analyst-views
guards80 ( Date: 02-Sep-2020 16:10) Posted:
|
Good.. the longer the foreplay, the greater the feeling .. lmao..
Since already waited so long, jz sit back and enjoy.. like what our fellow forumer limjoseph said..
Since already waited so long, jz sit back and enjoy.. like what our fellow forumer limjoseph said..
3dw1nchu4 ( Date: 02-Sep-2020 16:19) Posted:
|
Somehow all the TP in the world failed to move this stock. Hope for different this time
guards80 ( Date: 02-Sep-2020 16:10) Posted:
|
SRI TRANG AGRO: An alpha pick for Sept 2020 by UOBKH
http://www.nextinsight.net/story-archive-mainmenu-60/943-2020/13745-sri-trang-agro-an-alpha-pick-for-sept-2020-by-uobkh
Just wondering why the mention of his name to my comments?
That guy disappear or not....doesnt matter to our investment decision does it
He has informed that he be away for business ! Y ?
Greenpig ( Date: 01-Sep-2020 22:23) Posted:
|